Fingerprint
Dive into the research topics of 'Pembrolizumab in patients with extensive-stage small-cell lung cancer: Results from the phase Ib KEYNOTE-028 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab in patients with extensive-stage small-cell lung cancer: Results from the phase Ib KEYNOTE-028 study
Patrick A. Ott, Elena Elez, Sandrine Hiret, Dong Wan Kim, Anne Morosky, Sanatan Saraf, Bilal Piperdi, Janice M. Mehnert
Research output: Contribution to journal › Article › peer-review
392
Scopus
citations